Business Description
OptiBiotix Health PLC
NAICS : 561499
ISIN : GB00BP0RTP38
Description
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.58 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.1 | |||||
| 3-Year FCF Growth Rate | -7.2 | |||||
| 3-Year Book Growth Rate | -10.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.67 | |||||
| 9-Day RSI | 46.45 | |||||
| 14-Day RSI | 42.17 | |||||
| 6-1 Month Momentum % | -4.55 | |||||
| 12-1 Month Momentum % | -45.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.18 | |||||
| Quick Ratio | 5.36 | |||||
| Cash Ratio | 4.04 | |||||
| Days Inventory | 256.9 | |||||
| Days Sales Outstanding | 300.21 | |||||
| Days Payable | 362.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.2 | |||||
| Shareholder Yield % | -10.49 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.98 | |||||
| Operating Margin % | -351.67 | |||||
| Net Margin % | -524.43 | |||||
| FCF Margin % | -296.25 | |||||
| ROE % | -35.39 | |||||
| ROA % | -32.73 | |||||
| ROIC % | -25.37 | |||||
| 3-Year ROIIC % | 14.76 | |||||
| ROC (Joel Greenblatt) % | -565.57 | |||||
| ROCE % | -26.75 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 20.83 | |||||
| PB Ratio | 1.67 | |||||
| Price-to-Tangible-Book | 2.14 | |||||
| EV-to-EBIT | -4.76 | |||||
| EV-to-EBITDA | -5.25 | |||||
| EV-to-Forward-EBITDA | -41.14 | |||||
| EV-to-Revenue | 19.67 | |||||
| EV-to-Forward-Revenue | 4.97 | |||||
| EV-to-FCF | -6.64 | |||||
| Price-to-Net-Current-Asset-Value | 15 | |||||
| Price-to-Net-Cash | 15 | |||||
| Earnings Yield (Greenblatt) % | -21.01 | |||||
| FCF Yield % | -13.77 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers